Ixazomib as consolidation and maintenance versus observation in patients with relapsed multiple myeloma eligible for salvage autologous stem-cell transplantation (Myeloma XII [ACCoRD]): interim analysis of a multicentre, open-label, randomised, phase 3 trial

Cook, G., Ashcroft, A.J., Senior, E. et al. (17 more authors) (2024) Ixazomib as consolidation and maintenance versus observation in patients with relapsed multiple myeloma eligible for salvage autologous stem-cell transplantation (Myeloma XII [ACCoRD]): interim analysis of a multicentre, open-label, randomised, phase 3 trial. The Lancet Haematology, 11 (11). e816-e829. ISSN 2352-3026

Abstract

Metadata

Item Type: Article
Authors/Creators:
  • Cook, G.
  • Ashcroft, A.J.
  • Senior, E.
  • Olivier, C.
  • Hockaday, A.
  • Richards, J.
  • Cavenagh, J.D.
  • Snowden, J.A.
  • Drayson, M.T.
  • de Tute, R.
  • Roberts, L.
  • Owen, R.G.
  • Yong, K.
  • Garg, M.
  • Boyd, K.
  • Sati, H.
  • Gillson, S.
  • Cook, M.
  • Cairns, D.A. ORCID logo https://orcid.org/0000-0002-2338-0179
  • Parrish, C.
Copyright, Publisher and Additional Information:

© 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.

Dates:
  • Published: November 2024
  • Published (online): 6 September 2024
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Inst of Clinical Trials Research (LICTR) (Leeds)
Funding Information:
Funder
Grant number
Cancer Research UK Supplier No: 138573
A25447
Cancer Research UK Supplier No: 138573
CTUQQR-Dec22/100002
NIHR National Inst Health Research
Not Known
Millennium Pharmaceuticals Inc.
X16045
Cancer Research UK Supplier No: 138573
A19272
Depositing User: Symplectic Publications
Date Deposited: 09 Sep 2024 09:58
Last Modified: 04 Dec 2024 14:56
Status: Published
Publisher: Elsevier
Identification Number: 10.1016/s2352-3026(24)00249-7
Open Archives Initiative ID (OAI ID):

Export

Statistics